Cargando…

Development of a Deep-Learning-Based Artificial Intelligence Tool for Differential Diagnosis between Dry and Neovascular Age-Related Macular Degeneration

The use of deep-learning-based artificial intelligence (AI) is emerging in ophthalmology, with AI-mediated differential diagnosis of neovascular age-related macular degeneration (AMD) and dry AMD a promising methodology for precise treatment strategies and prognosis. Here, we developed deep learning...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heo, Tae-Young, Kim, Kyoung Min, Min, Hyun Kyu, Gu, Sun Mi, Kim, Jae Hyun, Yun, Jaesuk, Min, Jung Kee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277105/ https://www.ncbi.nlm.nih.gov/pubmed/32354098 http://dx.doi.org/10.3390/diagnostics10050261

Ejemplares similares

Artificial intelligence-based predictions in neovascular age-related macular degeneration
por: Ferrara, Daniela, et al.
Publicado: (2021)

Artificial intelligence for morphology-based function prediction in neovascular age-related macular degeneration
por: von der Emde, Leon, et al.
Publicado: (2019)

Development of a Fundus Image-Based Deep Learning Diagnostic Tool for Various Retinal Diseases
por: Kim, Kyoung Min, et al.
Publicado: (2021)

Alpinumisoflavone ameliorates choroidal neovascularisation and fibrosis in age-related macular degeneration in in vitro and in vivo models
por: Yu, Eunhye, et al.
Publicado: (2022)

Combined Treatment of Photodynamic Therapy and Bevacizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
por: Kim, Hyun Woong, et al.
Publicado: (2011)

Segmentation of macular neovascularization and leakage in fluorescein angiography images in neovascular age-related macular degeneration using deep learning
por: Holomcik, David, et al.
Publicado: (2022)

Trends in the Approval and Quality Management of Artificial Intelligence Medical Devices in the Republic of Korea
por: Lim, Kyoungtaek, et al.
Publicado: (2022)

Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR
por: Freund, K. Bailey, et al.
Publicado: (2022)

Histology of neovascular myopic macular degeneration
por: Jonas, Shefali B., et al.
Publicado: (2021)

Comparison of treatment methods for submacular hemorrhage in neovascular age-related macular degeneration: conservative versus active surgical strategy
por: Mun, Yongseok, et al.
Publicado: (2022)

Ranibizumab in neovascular age-related macular degeneration
por: Eng, Kenneth T, et al.
Publicado: (2006)

Twenty Years of Anti-Vascular Endothelial Growth Factor Therapeutics in Neovascular Age-Related Macular Degeneration Treatment
por: Moon, Bo-Hyun, et al.
Publicado: (2023)

Transient accumulation of subretinal fluid after half-fluence photodynamic therapy in neovascular age-related macular degeneration
por: Kim, Min Ho, et al.
Publicado: (2021)

Quantitative Analysis of OCT for Neovascular Age-Related Macular Degeneration Using Deep Learning
por: Moraes, Gabriella, et al.
Publicado: (2021)

Comment on: ‘You’ve got dry macular degeneration, end of story: a qualitative study into the experience of living with non-neovascular age-related macular degeneration’
por: Gandhi, Jagdeep Singh
Publicado: (2019)

Correction: ‘You’ve got dry macular degeneration, end of story’: a qualitative study into the experience of living with non-neovascular age-related macular degeneration
por: Taylor, Deanna J., et al.
Publicado: (2019)

Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor
por: Moon, Da Ru Chi, et al.
Publicado: (2015)

Outer nuclear layer recovery as a predictor of visual prognosis in type 1 choroidal neovascularization of neovascular age-related macular degeneration
por: Lee, Seungheon, et al.
Publicado: (2023)

Radiation therapy for neovascular age-related macular degeneration
por: Petrarca, Robert, et al.
Publicado: (2011)

Experimental Models in Neovascular Age Related Macular Degeneration
por: Rastoin, Olivia, et al.
Publicado: (2020)

Pipeline therapies for neovascular age related macular degeneration
por: Arepalli, Sruthi, et al.
Publicado: (2021)

Association of neovascular age-related macular degeneration with migraine
por: Kuang, Tung-Mei, et al.
Publicado: (2022)

Artificial intelligence-based decision-making for age-related macular degeneration
por: Hwang, De-Kuang, et al.
Publicado: (2019)

Evolution of macular atrophy in eyes with neovascular age-related macular degeneration compared to fellow non-neovascular eyes
por: Blazaki, Styliani, et al.
Publicado: (2023)

Monthly Alternating Injections of Aflibercept and Bevacizumab for Neovascular Age-Related Macular Degeneration
por: Lee, Junyeop, et al.
Publicado: (2022)

Response to ‘Comment on: ‘You have got dry macular degeneration, end of story’: a qualitative study into the experience of living with non-neovascular age-related macular degeneration’
por: Taylor, Deanna J., et al.
Publicado: (2019)

Dry Eye and Meibomian Gland Dysfunction in Neovascular Age-Related Macular Degeneration Patients Treated with Intravitreal Injections
por: Kıyat, Pelin, et al.
Publicado: (2022)

Real-world use of ranibizumab for neovascular age-related macular degeneration in Taiwan
por: Chang, Yi-Sheng, et al.
Publicado: (2018)

Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
por: Ahmed, Daniel, et al.
Publicado: (2020)

Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration
por: Arrigo, Alessandro, et al.
Publicado: (2021)

Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
por: Ferro Desideri, Lorenzo, et al.
Publicado: (2023)

CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration
por: Koo, Taeyoung, et al.
Publicado: (2018)

Predicting treat-and-extend outcomes and treatment intervals in neovascular age-related macular degeneration from retinal optical coherence tomography using artificial intelligence
por: Bogunović, Hrvoje, et al.
Publicado: (2022)

Association of Keratin 8 Level in Aqueous Humor With Outcomes of Intravitreal Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration
por: Shin, Joo Youn, et al.
Publicado: (2022)

Deep Learning-Based Artificial Intelligence for Mammography
por: Yoon, Jung Hyun, et al.
Publicado: (2021)

Increase in the Population of Patients with Neovascular Age-Related Macular Degeneration Who Underwent Long-Term Active Treatment
por: Baek, Seung Kook, et al.
Publicado: (2019)

Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration
por: Hurley, Susan F, et al.
Publicado: (2008)

Treatment of neovascular age-related macular degeneration: Current therapies
por: Augustin, Albert J, et al.
Publicado: (2009)

Treatment of neovascular age-related macular degeneration in patients with diabetes
por: Cummings, Michael, et al.
Publicado: (2008)

Phacoemulsification Surgery in Eyes with Neovascular Age-Related Macular Degeneration
por: Grixti, Andre, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9rs432ak9l811bljkk0enrbtov